Filing Details
- Accession Number:
- 0001193805-21-000368
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-03-15 17:05:04
- Reporting Period:
- 2021-03-02
- Accepted Time:
- 2021-03-15 17:05:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1280776 | Immunic Inc. | IMUX | Pharmaceutical Preparations (2834) | 562358443 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1850468 | Andreas Muehler | 1200 Avenue Of The Americas Suite 200 New York City NY 10036 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-03-02 | 10,006 | $15.54 | 294,486 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Reflects the weighted average price of 10,006 shares of common stock of Immunic, Inc. purchased by the Reporting Person in multiple transactions on March 2, 2021 with sale prices ranging from $14.44 to $15.72 per share. The Reporting Person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased at each separate price.
- Consists of 10,006 shares of common stock held directly by the Reporting Person, and 284,480 shares of common stock held indirectly by Xanomed GmbH, an entity controlled by the Reporting Person.
Billionaire Hedge Funds
